Event Videos

Disclaimer

Last updated: (10th May 2019)

The information ( service)contained on this website pertaining to Childrens liverindia.org /Chlildrens liver foundation ( CLF) is for general information purposes only. CLF ,inter alia includes its Trustees, office bearers, activists , staff , associates . CLF assumes no responsibility for errors or omissions in the contents of this website.

Read more

Glutathione peroxidase and malondialdehyde in children with chronic hepatitis C.

https://www.ncbi.nlm.nih.gov/pubmed/30915411 Hepatitis C

Clin Exp Hepatol. 2019 Mar;5(1):81-87. doi: 10.5114/ceh.2019.83161. Epub 2019 Feb 20.

Glutathione peroxidase and malondialdehyde in children with chronic hepatitis C.

Khedr MA1, El-Araby HA1, Konsowa HA1, Sokar SS2, Mahmoud MF1, Adawy NM1, Zakaria HM3.

Abstract

AIM OF THE STUDY:
We aimed to assess oxidative stress factors, glutathione peroxidase (GPX) and malondialdehyde (MDA) in children with chronic hepatitis C (CHC) and their relation to treatment response.

MATERIAL AND METHODS:

Published on: 
Mar-2019
Read more

Revised DIET for wilson disease patients

FOOD ITEMS THAT CAN BE CONSUMED BY WILSON DISEASE PATIENTS (Reference National Institute of Nutrition 2017)

  • DAIRY – Milk, curd, Khoa, Ghee, Cheese, Paneer
  • Rice / Wheat / Jawar / Bajra / Makka / Ragi
  • All vegetables
  • All fruits
  • Egg
  • Fish Prawns
  • Chicken
  • Red meat – Mutton /Sheep / Beef
  • Jaggery
  • Tea / Coffee
  • Spices except cumin, corianderseed, black pepper, mace
  • Bengalgram Dal (Chola / Chana), Moong, Masoor, Urad dal,
  • Mushrooms

AVOID

PreviewAttachmentSize
diet_wd_resvised.pdf22.38 KB
Read more

Increased serum glypican-3 is associated with liver stiffness and hepatic dysfunction in children with biliary atresia.

https://www.ncbi.nlm.nih.gov/pubmed/30915406 Biliary atresia
Clin Exp Hepatol. 2019 Mar;5(1):48-54. doi: 10.5114/ceh.2019.83156. Epub 2019 Feb 20.
Increased serum glypican-3 is associated with liver stiffness and hepatic dysfunction in children with biliary atresia.
Sirisomboonlarp K1, Udomsinprasert W1,2, McConachie E1, Woraruthai T1, Poovorawan Y3, Honsawek S1.

Abstract

AIM OF THE STUDY:

Published on: 
Mar-2019
Read more

Development and validation of a new simplified diagnostic scoring system for pediatric autoimmune hepatitis.

https://www.ncbi.nlm.nih.gov/pubmed/30928421 Autoimmune hepatitis
Dig Liver Dis. 2019 Mar 27. pii: S1590-8658(19)30104-5. doi: 10.1016/j.dld.2019.02.018. [Epub ahead of print]
Development and validation of a new simplified diagnostic scoring system for pediatric autoimmune hepatitis.
Arcos-Machancoses JV1, Molera Busoms C2, Julio Tatis E3, Bovo MV4, Quintero Bernabeu J5, Juampérez Goñi J6, Crujeiras Martínez V7, Martín de Carpi J8.

Author information

Abstract

BACKGROUND:
Children with autoimmune hepatitis (AIH) often exhibit particular features. Accordingly, seven pediatric-specific criteria have been proposed.

AIM:
To develop a prediction model based on them, transform it into a scoring system and study its accuracy.

METHODS:

Published on: 
Mar-2019
Read more

Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension.

https://www.ncbi.nlm.nih.gov/pubmed/30921261 Portal hypertension
J Pediatr Gastroenterol Nutr. 2019 Mar 26. doi: 10.1097/MPG.0000000000002327. [Epub ahead of print]
Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension.
Ebel NH1, Carlin K2, Shaffer ML3, Shivaram G4, Hawkins CM5, Lane ER6, Cooper K2, Lindquester WS7, Gadodia G8, Murray KF2,6.

Author information

Abstract

OBJECTIVES:

Published on: 
Mar-2019
Read more

Intra-patient variability in tacrolimus exposure in pediatric liver transplant recipients: Evolution, risk factors, and impact on patient outcomes

https://www.ncbi.nlm.nih.gov/pubmed/30916883 Liver transplant
Pediatr Transplant. 2019 Mar 27:e13388. doi: 10.1111/petr.13388. [Epub ahead of print]
Intra-patient variability in tacrolimus exposure in pediatric liver transplant recipients: Evolution, risk factors, and impact on patient outcomes.
Defrancq C1, De Wilde N1, Raes A1,2, Van Biervliet S3, Vande Velde S3, Van Winckel M3, De Bruyne R3, Prytuła A1.
Author information

Abstract

BACKGROUND:
This study aims to investigate the evolution and factors associated with TAC IPV and its impact on patient outcomes in pediatric LT recipients.

METHODS:

Published on: 
Mar-2019
Read more

Partial Splenic Embolization is a Safe and Effective Alternative in the Management of Portal Hypertension in Children.

https://www.ncbi.nlm.nih.gov/pubmed/30908386 Portal hypertension
J Pediatr Gastroenterol Nutr. 2019 Mar 18. doi: 10.1097/MPG.0000000000002332. [Epub ahead of print]
Partial Splenic Embolization is a Safe and Effective Alternative in the Management of Portal Hypertension in Children.
Vittorio J1, Orellana K, Martinez M1, Ovchinsky N, Schlossberg P2, Griesemer A3, Lobritto S1.

Abstract

OBJECTIVE:

There are multiple approaches to manage the clinical complications of portal hypertension (PHTN) to treat/prevent spontaneous hemorrhage by mitigating thrombocytopenia. No single approach is ideal for all patients given the heterogeneity of this population. Our goal was to determine whether partial splenic embolization (PSE) was safe and effective in the pediatric population.

Published on: 
Mar-2019
Read more
« first ‹ previous … 83 84 85 86 87 88 89 90 91 … next › last »

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: